Glenmark Life SciencesGLS 
$12.47-0.24%24h
-0.24%24h
Global rank6154
Market cap$1.53B
Change 7d6.67%
YTD Performance58.63%
SP500 benchmarkOutperform
P/E0.33
P/S6.25
Revenue$244.33M
Earnings$55.71M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Glenmark Life Sciences (GLS)
Glenmark Life Sciences has an EPS of $38.11. In 2022, the company made an earnings per share (EPS) of $35.63. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for GLS
-
Value:-
EPS history for Glenmark Life Sciences from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $38.11 | 6.96% |
| 2022 | $35.63 | 24.17% |
| 2021 | $28.69 | 12.29% |
| 2020 | $25.55 | - |
View the highest EPS stocks
